X
Meril Life

₹0.00

mrf 0.00%
13 Nov 4:01 p.m.

Listing Status:

Connect: •••
•••• ••••
•••
Key Metrics of Meril
  • Market Cap
  • Total Equity Funding ₹2,427 Cr in 2 rounds
  • Latest Funding Round ₹860 Cr, Series C Jul 21, 2025
  • Post Money Valuation
  • Annual Revenue ₹4,992 Cr
    ▲ 40% YoYas on Mar 31, 2025
  • EBITDA ₹1,383 Cr
    ▲ 85% YoYas on Mar 31, 2025
  • EBITDA Margin 27.71%
    ▲ 32% YoYas on Mar 31, 2025
  • Net Profit ₹729 Cr
    ▲ 119% YoYas on Mar 31, 2025
  • Net Profit Margin 14.61%
    ▲ 57% YoYas on Mar 31, 2025
About the Company

Manufacturer of medical devices including vascular intervention products, orthopedic implants, robotics, endo-surgery equipment, and diagnostic solutions. This entity designs and...

Loading...
Price on BSE Volume

Funding Rounds

Total Rounds: 2 Merillife

S.No. Date Round Name Amount TTM Revenue Investors & Facilitators
1. Jul 21, 2025 Series C ₹860 Cr ₹5,724 Cr
Inst: ADIA
Facil: AZB & Partners
2. Feb 22, 2022 PE ₹1,567 Cr -
Inst: Warburg Pincus

Financial Statements

Revenue - INR (Cr)

Net Profit/Loss - INR (Cr)

Select a year from the tabs

FY 24-25
FY 23-24
FY 22-23
FY 21-22
FY 20-21
FY 19-20
FY 18-19
FY 17-18
FY 16-17
FY 15-16
FY 14-15
FY 13-14
Detailed Income StatementFY 24-25 (in Cr)
4,992.2
3,996.0
Total profit before exceptional items, extraordinary items and tax 996.2
Total profit before tax 996.2
266.8
Total profit (loss) for period from continuing operations 729.4
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period 729.4
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 24-25 (in Cr)
7,494.2
7,494.2
Detailed Cash Flow StatementFY 24-25 (in Cr)
Net cash from / (used in) operating activities 125.6
Net cash from / (used in) investing activities (655.1)
Net cash from / (used) in financing activities 568.0
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 38.5
Net increase / (decrease) in cash and cash equivalents 38.5
Cash and cash equivalents at the beginning of the year 64.1
Cash and cash equivalents at the end of the year 102.6
Detailed Income StatementFY 23-24 (in Cr)
3,570.2
3,081.6
Total profit before exceptional items, extraordinary items and tax 488.5
Total profit before tax 488.5
155.7
Total profit (loss) for period from continuing operations 332.8
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period 332.8
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 23-24 (in Cr)
5,762.2
5,762.2
Detailed Cash Flow StatementFY 23-24 (in Cr)
Net cash from / (used in) operating activities (206.8)
Net cash from / (used in) investing activities (670.7)
Net cash from / (used) in financing activities 873.5
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (4.0)
Net increase / (decrease) in cash and cash equivalents (4.0)
Cash and cash equivalents at the beginning of the year 68.1
Cash and cash equivalents at the end of the year 64.1
Detailed Income StatementFY 22-23 (in Cr)
2,716.4
2,042.3
Total profit before exceptional items, extraordinary items and tax 674.1
Exceptional items before tax 10.7
Total profit before tax 684.8
179.9
Total profit (loss) for period from continuing operations 504.9
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period 504.9
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 22-23 (in Cr)
4,050.2
4,050.2
Detailed Cash Flow StatementFY 22-23 (in Cr)
Net cash from / (used in) operating activities 45.1
Net cash from / (used in) investing activities (1,830.3)
Net cash from / (used) in financing activities 1,753.1
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (32.0)
Effect of exchange rate changes on cash and cash equivalents 47.4
Net increase / (decrease) in cash and cash equivalents 15.4
Cash and cash equivalents at the beginning of the year 52.7
Cash and cash equivalents at the end of the year 68.1
Detailed Income StatementFY 21-22 (in Cr)
1,673.2
1,480.0
Total profit before exceptional items, extraordinary items and tax 193.2
Exceptional items before tax 5.9
Total profit before tax 199.1
41.4
Total profit (loss) for period from continuing operations 157.6
Total profit (loss) for period 157.6
Detailed Balance SheetFY 21-22 (in Cr)
1,667.6
1,667.6
Detailed Cash Flow StatementFY 21-22 (in Cr)
Net cash from / (used in) operating activities 219.4
Net cash from / (used in) investing activities (83.0)
Net cash from / (used) in financing activities (103.7)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 32.7
Effect of exchange rate changes on cash and cash equivalents 0
Net increase / (decrease) in cash and cash equivalents 32.7
Cash and cash equivalents at the beginning of the year 19.9
Cash and cash equivalents at the end of the year 52.7
Detailed Income StatementFY 20-21 (in Cr)
2.3
7.5
Total profit before prior period items, exceptional items, extraordinary items and tax 0
Exceptional items before tax 0
Total profit before extraordinary items and tax 0
Extraordinary items before tax 0
Total profit before tax (5.2)
(0.0)
Total profit (loss) for period from continuing operations (5.2)
Detailed Balance SheetFY 20-21 (in Cr)
159.5
159.5
Detailed Cash Flow StatementFY 20-21 (in Cr)
Cash flow from operating activities 0
Net cash from/(used in) operating activities (0.3)
Cash flow from investing activities 0
Net cash from/(used in) investing activities 0.2
Cash flow from financing activities 0
Net cash from/(used) in financing activities 0
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes (0.0)
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents (0.0)
Cash and cash equivalents at the beginning of the year 0.1
Cash and cash equivalents at the end of the year 0.1
Detailed Income StatementFY 19-20 (in Cr)
4.4
7.8
Total profit before prior period items, exceptional items, extraordinary items and tax 0
Exceptional items before tax 0
Total profit before extraordinary items and tax 0
Extraordinary items before tax 0
Total profit before tax (3.4)
0.3
Total profit (loss) for period from continuing operations (3.7)
Detailed Balance SheetFY 19-20 (in Cr)
157.4
157.4
Detailed Cash Flow StatementFY 19-20 (in Cr)
Cash flow from operating activities 0
Net cash from/(used in) operating activities (1.0)
Cash flow from investing activities 0
Net cash from/(used in) investing activities 1.1
Cash flow from financing activities 0
Net cash from/(used) in financing activities 0
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes 0.1
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents 0.1
Cash and cash equivalents at the beginning of the year 0.0
Cash and cash equivalents at the end of the year 0.1
Detailed Income StatementFY 18-19 (in Cr)
2.8
7.0
Total profit before prior period items, exceptional items, extraordinary items and tax 0
Exceptional items before tax 0
Total profit before extraordinary items and tax 0
Extraordinary items before tax 0
Total profit before tax (4.2)
0.0
Total profit (loss) for period from continuing operations (4.2)
Detailed Balance SheetFY 18-19 (in Cr)
153.9
153.9
Detailed Cash Flow StatementFY 18-19 (in Cr)
Cash flow from operating activities 0
Net cash from/(used in) operating activities (0.2)
Cash flow from investing activities 0
Net cash from/(used in) investing activities 0.2
Cash flow from financing activities 0
Net cash from/(used) in financing activities 0
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes (0.0)
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents (0.0)
Cash and cash equivalents at the beginning of the year 0.0
Cash and cash equivalents at the end of the year 0.0
Detailed Income StatementFY 17-18 (in Cr)
3.1
6.5
Total profit before prior period items, exceptional items, extraordinary items and tax 0
Exceptional items before tax 0
Total profit before extraordinary items and tax 0
Extraordinary items before tax 0
Total profit before tax (3.4)
0.0
Total profit (loss) for period from continuing operations (3.5)
Detailed Balance SheetFY 17-18 (in Cr)
151.4
151.4
Detailed Cash Flow StatementFY 17-18 (in Cr)
Cash flow from operating activities 0
Net cash from/(used in) operating activities (0.2)
Cash flow from investing activities 0
Net cash from/(used in) investing activities 0.2
Cash flow from financing activities 0
Net cash from/(used) in financing activities 0
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes (0.0)
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents (0.0)
Cash and cash equivalents at the beginning of the year 0.0
Cash and cash equivalents at the end of the year 0.0
Detailed Income StatementFY 16-17 (in Cr)
0.0
0.6
Total profit before prior period items, exceptional items, extraordinary items and tax (0.6)
Exceptional items before tax 0
Total profit before extraordinary items and tax (0.6)
Extraordinary items before tax 0
Total profit before tax (0.6)
0.0
Total profit (loss) for period from continuing operations (0.6)
Detailed Balance SheetFY 16-17 (in Cr)
159.7
159.7
Detailed Cash Flow StatementFY 16-17 (in Cr)
Cash flow from operating activities (0.6)
Net cash from/(used in) operating activities (0.6)
Cash flow from investing activities (0.4)
Net cash from/(used in) investing activities (0.4)
Cash flow from financing activities 1.0
Net cash from/(used) in financing activities 1.0
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes (0.0)
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents (0.0)
Cash and cash equivalents at the beginning of the year 0.0
Cash and cash equivalents at the end of the year 0.0
Detailed Income StatementFY 15-16 (in Cr)
0
0.1
Total profit before prior period items, exceptional items, extraordinary items and tax (0.1)
Exceptional items before tax 0
Total profit before extraordinary items and tax (0.1)
Extraordinary items before tax 0
Total profit before tax (0.1)
0
Total profit (loss) for period from continuing operations (0.1)
Detailed Balance SheetFY 15-16 (in Cr)
159.3
159.3
Detailed Cash Flow StatementFY 15-16 (in Cr)
Cash flow from operating activities (0.0)
Net cash from/(used in) operating activities (0.0)
Cash flow from investing activities 0
Net cash from/(used in) investing activities 0
Cash flow from financing activities 0
Net cash from/(used) in financing activities 0
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes (0.0)
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents (0.0)
Cash and cash equivalents at the beginning of the year 0.0
Cash and cash equivalents at the end of the year 0.0
Detailed Income StatementFY 14-15 (in Cr)
0
0.0
Total profit before prior period items, exceptional items, extraordinary items and tax (0.0)
Exceptional items before tax 0
Total profit before extraordinary items and tax (0.0)
Extraordinary items before tax 0
Total profit before tax (0.0)
0
Total profit (loss) for period from continuing operations (0.0)
Detailed Balance SheetFY 14-15 (in Cr)
159.3
159.3
Detailed Cash Flow StatementFY 14-15 (in Cr)
Cash flow from operating activities (0.0)
Net cash from/(used in) operating activities (0.0)
Cash flow from investing activities 0
Net cash from/(used in) investing activities 0
Cash flow from financing activities 0
Net cash from/(used) in financing activities 0
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes (0.0)
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents (0.0)
Cash and cash equivalents at the beginning of the year 0.0
Cash and cash equivalents at the end of the year 0.0
Detailed Income StatementFY 13-14 (in Cr)
0
0.1
Total profit before prior period items, exceptional items, extraordinary items and tax (0.1)
Exceptional items before tax 0
Total profit before extraordinary items and tax (0.1)
Extraordinary items before tax 0
Total profit before tax (0.1)
0
Total profit (loss) for period from continuing operations (0.1)
Detailed Balance SheetFY 13-14 (in Cr)
159.3
159.3
Detailed Cash Flow StatementFY 13-14 (in Cr)
Cash flow from operating activities (0.0)
Net cash from/(used in) operating activities (0.0)
Cash flow from investing activities (0.0)
Net cash from/(used in) investing activities (0.0)
Cash flow from financing activities 0
Net cash from/(used) in financing activities 0
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes (0.0)
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents (0.0)
Cash and cash equivalents at the beginning of the year 0.1
Cash and cash equivalents at the end of the year 0.0

Top Competitors

Similar companies to Merillife

Boston Scientific

bostonscientific.com

Abbott

abbott.com

Medtronic

medtronic.com

BD

bd.com

Danaher

danaher.com

Trivitron

trivitron.com

Latest News

Updates on Merillife
Need help? Chat with us! WhatsApp